Novavax stockholders approve director elections, advisory pay, and equity plan share increases

NOVAVAX INC

Stockholders elected Class II directors Richard Douglas, Margaret McGlynn, and David Mott with majorities (approx. 25.5M, 22.9M, 23.1M For).
Advisory vote on 2023 executive compensation passed: 24.2M For, 8.7M Against, 11.0M Abstain.
Amended 2015 Stock Incentive Plan approved (22.4M For, 20.9M Against), adding 6.5M shares to the pool.
Amended 2013 Employee Stock Purchase Plan approved (23.2M For, 10.0M Abstain), adding 1M shares with annual increase formula.
Ratification of Ernst & Young as auditor for FY2024 passed overwhelmingly (69.0M For).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.